Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Chemoprevention of head and neck squamous cell carcinoma through inhibition of NF-κB signaling.

Vander Broek R, Snow GE, Chen Z, Van Waes C.

Oral Oncol. 2014 Oct;50(10):930-41. doi: 10.1016/j.oraloncology.2013.10.005. Epub 2013 Oct 28. Review.

3.

Evidence that TNF-TNFR1-TRADD-TRAF2-RIP-TAK1-IKK pathway mediates constitutive NF-kappaB activation and proliferation in human head and neck squamous cell carcinoma.

Jackson-Bernitsas DG, Ichikawa H, Takada Y, Myers JN, Lin XL, Darnay BG, Chaturvedi MM, Aggarwal BB.

Oncogene. 2007 Mar 1;26(10):1385-97. Epub 2006 Sep 4.

PMID:
16953224
4.

Guggulsterone (GS) inhibits smokeless tobacco and nicotine-induced NF-κB and STAT3 pathways in head and neck cancer cells.

Macha MA, Matta A, Chauhan SS, Siu KW, Ralhan R.

Carcinogenesis. 2011 Mar;32(3):368-80. doi: 10.1093/carcin/bgq278. Epub 2010 Dec 22.

PMID:
21177768
5.

MEK Inhibitor PD-0325901 Overcomes Resistance to PI3K/mTOR Inhibitor PF-5212384 and Potentiates Antitumor Effects in Human Head and Neck Squamous Cell Carcinoma.

Mohan S, Vander Broek R, Shah S, Eytan DF, Pierce ML, Carlson SG, Coupar JF, Zhang J, Cheng H, Chen Z, Van Waes C.

Clin Cancer Res. 2015 Sep 1;21(17):3946-56. doi: 10.1158/1078-0432.CCR-14-3377. Epub 2015 May 14.

6.
7.

Curcumin inhibits carcinogen and nicotine-induced Mammalian target of rapamycin pathway activation in head and neck squamous cell carcinoma.

Clark CA, McEachern MD, Shah SH, Rong Y, Rong X, Smelley CL, Caldito GC, Abreo FW, Nathan CO.

Cancer Prev Res (Phila). 2010 Dec;3(12):1586-95. doi: 10.1158/1940-6207.CAPR-09-0244. Epub 2010 Sep 17.

8.

Role of activated nuclear factor-kappaB in the pathogenesis and therapy of squamous cell carcinoma of the head and neck.

Allen CT, Ricker JL, Chen Z, Van Waes C.

Head Neck. 2007 Oct;29(10):959-71. Review.

PMID:
17405170
9.

Bortezomib-induced apoptosis with limited clinical response is accompanied by inhibition of canonical but not alternative nuclear factor-{kappa}B subunits in head and neck cancer.

Allen C, Saigal K, Nottingham L, Arun P, Chen Z, Van Waes C.

Clin Cancer Res. 2008 Jul 1;14(13):4175-85. doi: 10.1158/1078-0432.CCR-07-4470.

10.

Inhibition of growth and survival of human head and neck squamous cell carcinoma cells by curcumin via modulation of nuclear factor-kappaB signaling.

Aggarwal S, Takada Y, Singh S, Myers JN, Aggarwal BB.

Int J Cancer. 2004 Sep 20;111(5):679-92. Erratum in: Int J Cancer. 2004 Dec 20;112(6):1086.

11.

Attenuated transforming growth factor beta signaling promotes nuclear factor-kappaB activation in head and neck cancer.

Cohen J, Chen Z, Lu SL, Yang XP, Arun P, Ehsanian R, Brown MS, Lu H, Yan B, Diallo O, Wang XJ, Van Waes C.

Cancer Res. 2009 Apr 15;69(8):3415-24. doi: 10.1158/0008-5472.CAN-08-3704. Epub 2009 Apr 7.

12.

Epigallocatechin-3-gallate decreases VEGF production in head and neck and breast carcinoma cells by inhibiting EGFR-related pathways of signal transduction.

Masuda M, Suzui M, Lim JT, Deguchi A, Soh JW, Weinstein IB.

J Exp Ther Oncol. 2002 Nov-Dec;2(6):350-9.

PMID:
12440226
13.

Prevention of head and neck squamous cell carcinoma: removing the "chemo" from "chemoprevention".

Saba NF, Haigentz M Jr, Vermorken JB, Strojan P, Bossi P, Rinaldo A, Takes RP, Ferlito A.

Oral Oncol. 2015 Feb;51(2):112-8. doi: 10.1016/j.oraloncology.2014.11.002. Epub 2014 Nov 26. Review.

PMID:
25434586
14.
15.

NF-κB participates in chemokine receptor 7-mediated cell survival in metastatic squamous cell carcinoma of the head and neck.

Liu FY, Zhao ZJ, Li P, Ding X, Guo N, Yang LL, Zong ZH, Sun CF.

Oncol Rep. 2011 Feb;25(2):383-91. doi: 10.3892/or.2010.1090. Epub 2010 Dec 9.

PMID:
21165563
16.

Targeting the epidermal growth factor receptor for head and neck cancer chemoprevention.

Mak MP, William WN Jr.

Oral Oncol. 2014 Oct;50(10):918-23. doi: 10.1016/j.oraloncology.2013.12.024. Epub 2014 Jan 10.

17.

Aberrant IKKα and IKKβ cooperatively activate NF-κB and induce EGFR/AP1 signaling to promote survival and migration of head and neck cancer.

Nottingham LK, Yan CH, Yang X, Si H, Coupar J, Bian Y, Cheng TF, Allen C, Arun P, Gius D, Dang L, Van Waes C, Chen Z.

Oncogene. 2014 Feb 27;33(9):1135-47. doi: 10.1038/onc.2013.49. Epub 2013 Mar 4.

19.
20.

Chemoprevention targets for tobacco-related head and neck cancer: past lessons and future directions.

Sheth SH, Johnson DE, Kensler TW, Bauman JE.

Oral Oncol. 2015 Jun;51(6):557-64. doi: 10.1016/j.oraloncology.2015.02.101. Epub 2015 Apr 11. Review.

PMID:
25868717

Supplemental Content

Support Center